Performance analysis of Aldeyra Therapeutics (ALDX)
Annual Return
Over the past 3 years, ALDX has had an average annual return of -39.77%, underperforming the benchmark SPY, which returned +19.62% annual.
Over the past 5 years, ALDX has had an average annual return of -28.22%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, ALDX has had an average annual return of -11.34%, underperforming the benchmark SPY, which returned +15.04% annual.
Since May 2, 2014, ALDX has had an average annual return of -10.92%, underperforming the benchmark SPY, which returned +13.87% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -66.21% | +3.79% | +42.17% | -49.57% | +73.99% | -41.69% | +18.08% | -30.01% | +22.07% | +27.09% | -21.09% | -6.09% |
| 2014 | |||||||||||
| +0.28% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.48% | +1.87% | -69.05% | -10.06% | +15.16% | +21.68% | -17.82% | -66.21% | |||||
| 2025 | +5.01% | -2.49% | +12.53% | -53.91% | -18.88% | +78.13% | +30.31% | +17.02% | -10.62% | -2.87% | +8.08% | -5.48% | +3.79% |
| 2024 | -10.83% | +15.67% | -9.67% | +20.48% | -2.03% | -14.25% | +19.03% | +46.07% | -6.34% | -2.40% | -6.84% | +1.84% | +42.17% |
| 2023 | -15.24% | +14.58% | +46.90% | -4.03% | -0.42% | -11.59% | -3.28% | -8.07% | -10.45% | -74.40% | +61.98% | +26.72% | -49.57% |
| 2022 | -8.26% | +10.08% | +10.03% | -30.94% | +0.66% | +29.12% | +26.31% | +39.69% | -24.15% | +2.24% | +2.57% | +24.29% | +73.99% |
| 2021 | +63.27% | +9.46% | -3.10% | +5.81% | -0.40% | -9.51% | -21.45% | +6.63% | -7.49% | +3.65% | -15.71% | -47.85% | -41.69% |
| 2020 | -8.08% | -28.84% | -34.99% | +27.51% | +56.18% | -15.23% | +54.20% | +1.55% | +13.49% | -9.85% | +5.24% | -2.42% | +18.08% |
| 2019 | +6.14% | -8.29% | +11.76% | -8.42% | -15.71% | -13.92% | -8.66% | -19.52% | +19.49% | +6.08% | +42.75% | -27.19% | -30.01% |
| 2018 | +9.93% | +10.36% | -9.09% | +4.67% | +7.01% | -5.36% | -12.58% | +21.58% | +63.32% | -21.96% | -16.71% | -7.47% | +22.07% |
| 2017 | +1.86% | -9.17% | +1% | -12.99% | +16.09% | -7.93% | +2.15% | -12.63% | +73.49% | -12.50% | +5.55% | +2.25% | +27.09% |
Drawdown analysis of Aldeyra Therapeutics (ALDX)
The maximum drawdown for the ALDX was -91.65%, occurring on Mar 17, 2026. This drawdown has not yet recovered.
The current ALDX drawdown is -88.21%.
Since May 2, 2014 ALDX has experienced the following drawdowns:
- 50% or more: 4 times
- 40% or more: 4 times
- 30% or more: 5 times
- 20% or more: 6 times
- 10% or more: 9 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -91.65% | Apr 27, 2021 | 1227 | Mar 17, 2026 | Ongoing | Ongoing | Ongoing |
| -88.71% | Sep 27, 2018 | 367 | Mar 16, 2020 | 232 | Feb 16, 2021 | 599 |
| -70.91% | Jan 30, 2015 | 268 | Feb 24, 2016 | 653 | Sep 26, 2018 | 921 |
| -56.32% | Jun 19, 2014 | 32 | Aug 5, 2014 | 54 | Oct 21, 2014 | 86 |
| -31.87% | Oct 29, 2014 | 40 | Dec 26, 2014 | 14 | Jan 16, 2015 | 54 |
| -27.60% | Feb 16, 2021 | 46 | Apr 22, 2021 | 3 | Apr 27, 2021 | 49 |
| -18.15% | May 15, 2014 | 11 | Jun 2, 2014 | 13 | Jun 19, 2014 | 24 |
| -16.81% | Jan 20, 2015 | 3 | Jan 23, 2015 | 2 | Jan 27, 2015 | 5 |
| -15.97% | May 2, 2014 | 3 | May 7, 2014 | 6 | May 15, 2014 | 9 |
| -9.55% | Oct 21, 2014 | 1 | Oct 22, 2014 | 3 | Oct 27, 2014 | 4 |